Nevin Varghese

Stock Analyst at RBC Capital

(2.41)

# 3,271

Out of 5,133 analysts

12

Total ratings

62.5%

Success rate

7%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Nevin Varghese

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PHVS Pharvaris	Maintained: Buy	$62 → $63	$33.83	+86.23%	7	Nov 14, 2026
	CLYM Climb Bio	Reiterated: Buy	$23	$10.87	+111.59%	4	Nov 5, 2026
	PRTA Prothena Corporation	Reiterated: Hold	$13	$8.23	+57.96%	1	Nov 5, 2026

Pharvaris

Nov 14, 2026

Maintained: Buy

Price Target: $62 → $63

Current: $33.83

Upside: +86.23%

Climb Bio

Nov 5, 2026

Reiterated: Buy

Price Target: $23

Current: $10.87

Upside: +111.59%

Prothena Corporation

Nov 5, 2026

Reiterated: Hold

Price Target: $13

Current: $8.23

Upside: +57.96%